Orexa is a clinical-stage pharmaceutical company that develops and commercialises therapeutics to increase food intake.
Orexa has raised €2.6M across 3 funding rounds, most recently a round in Feb 2024. Based in Herpen, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount |
|---|
| Investors |
|---|
| 2024-02-02 | Other | €870k | — | View deal → |
| 2023-01-12 | Other | €485k | — | View deal → |
| 2022-09-05 | Other | €1.2M | — | View deal → |
